James @ Kode
Stories (6)
Filter by community
Wearables as Continuous Diagnostic Inputs
Wearables are entering a new phase in healthcare. Once associated with step counts and wellness dashboards, they now provide continuous physiological signals with genuine diagnostic value. Heart-rate variability, sleep cycles, activity trends, recovery patterns, and sensor-derived biometrics are becoming essential inputs for precision, early detection and long-term condition management.
By James @ Kode4 days ago in Lifehack
Bringing Multi-Modal Intelligence to Early Clinical Recruitment
Clinical trials often fail to recruit the participants they were designed for. A protocol might specify a cohort defined by inflammatory markers, disease severity, a diagnostic pattern or a particular biological signature — but the moment recruitment begins, sites must make decisions using far simpler signals. Coordinators typically see a patient’s diagnosis code, age, medication list and whatever labs happen to be in the record. They rarely see the biomarker history. They cannot view longitudinal patterns. They cannot infer whether the patient is likely to meet a complex set of criteria. And they certainly cannot run new tests before screening.
By James @ Kodeabout a month ago in Lifehack
Operational Precision for Modern Trials
Sampling in clinical trials has become significantly more complex — often more quickly than the operational systems that support it. Many studies now involve multiple sample types, evolving biomarker panels, variant collection instructions, and multi-lab routing pathways. Protocol amendments introduce further movement, and sites vary widely in what they can handle.
By James @ Kodeabout a month ago in Lifehack
From Genomes to Epigenomes: The Expanding Role of Nanopore Sequencing in Diagnostics
For nearly two decades, microarrays and short-read next-generation sequencing (NGS) have been the workhorses of clinical genomics. SNP and methylation arrays remain cost-effective for genotyping and epigenetic profiling, while Illumina’s Sequencing-by-Synthesis and similar methodologies have similarly transformed diagnostics with targeted panels, whole-exome sequencing, and RNA-seq (Mardis, 2017). These families of technologies have underpinned diagnostics in oncology, rare disease, non-invasive prenatal testing, and infectious disease.
By James @ Kode3 months ago in Lifehack
The challenge of Omics Solution: End-to-end Omics Test Made Simple
The challenge of Omics Solutions: thousands of analyses from single datatypes. Omics tests are tests that rely on large biological datatypes, often times producing gigabytes of data. This data has to then be computed using bioinformatics algorithms, resulting in insights that can inform healthcare decisions, crops yields and much more.
By James @ Kode4 months ago in Lifehack
Building the Future of Diagnostics with AI-Powered Development
Design alone is no longer enough to bring transformative products to life. While great design sparks creativity and defines user experience, development is what turns vision into reality. At Hurdle, we believe that true innovation demands more than following a conventional design process-it requires a smarter, more holistic approach that aligns strategy, technology, and market readiness.
By James @ Kode5 months ago in Lifehack
